--2025/FY-- / 9.544B--
--2024/FY-- / 8.725B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--
CN Stock MarketDetailed Quotes
600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation
- 30.18
- +0.24+0.80%
Market Closed Jan 17 15:00 CST
23.24BMarket Cap24.92P/E (TTM)
30.29High29.80Low21.00KlotVolume29.85Open29.94Pre Close63.23MTurnover0.37%Turnover Ratio23.56P/E (Static)770.16MShares39.0552wk High3.62P/B17.11BFloat Cap22.1252wk Low32.93Limit Up567.09MShs Float53.86Historical High26.95Limit Down1.64%Amplitude-3.05Historical Low1.28Dividend TTM30.11Avg Price8.29KlotAsk4.24%Div YieldTTM100Lot Size12.12KlotBid
Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats
Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
